Skip to main content
logo
Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China flag China · Delayed Price · Currency is CNY
11.16
+0.06 (0.54%)
Apr 30, 2026, 3:04 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceutical and Health Product Manufacturing and Sales Business
523.14M----
Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business
3.73M----
Other Operations
17.63M---2.29M
Other Operations Growth
----75.60%
Offset of Business Segment
-206.82M----
Production and Sales of Western Medicine
----13.63M
Production and Sales of Western Medicine Growth
-----32.75%
Production and Sales of Traditional Chinese Medicine
----284.86M
Production and Sales of Traditional Chinese Medicine Growth
----12.36%
Medicine Manufacturing
--384.66M346.53M-
Medicine Manufacturing Growth
--11.01%--
Unallocated Others
--19.98M4.00M-
Unallocated Others Growth
--399.27%--
Total
337.67M-404.65M350.53M300.77M
Total Growth
--15.44%16.54%9.34%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
China
337.67M343.21M404.65M350.53M300.77M
China Growth
-1.61%-15.18%15.44%16.54%9.34%
Total
337.67M343.21M404.65M350.53M300.77M
Total Growth
-1.61%-15.18%15.44%16.54%9.34%
Source: S&P Global Market Intelligence.